{"version":"1.0","type":"link","title":"Camizestrant in combination with capivasertib for women with ER-positive, HER2-negative advanced breast cancer: results from SERENA-1.","author_name":"Vaklavas C 외","author_url":"https://prs-insight.online/author/Vaklavas%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/86829","thumbnail_width":1200,"thumbnail_height":630}